DARBY SMALE: Open Payments
NPI 1891254769 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 13 payments from 12 companies in 2025. Trend: 2023 $4,314 · 2024 $2,900 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $207 |
| JAZZ PHARMACEUTICALS INC. | 1 | $148 |
| GENZYME CORPORATION | 1 | $127 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Dexcom, Inc. | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Novo Nordisk Inc | 1 | $100 |
| Lilly USA, LLC | 1 | $99 |
Products named: BREZTRI, XYWAV, DUPIXENT, LUMRYZ, Ohtuvayre, DEXCOM G7 GSS (161), ACTHAR, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
